GALT vs BIIB: Which Stock is Better?
Side-by-side comparison of Galectin Therapeutics Inc and Biogen Inc in 2026
GALT
Galectin Therapeutics Inc
$2.26
BIIB
Biogen Inc
$176.02
Key Metrics Comparison
| Metric | GALT | BIIB | Winner |
|---|---|---|---|
| Market Cap | $168.52M | $25.83B | BIIB |
| P/E Ratio | N/A | 20.05 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze GALT
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GALT or BIIB a better investment?
Comparing GALT and BIIB: Galectin Therapeutics Inc has a market cap of $168.52M while Biogen Inc has $25.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GALT and BIIB?
GALT (Galectin Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GALT or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GALT or BIIB?
GALT has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: GALT or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for GALT.
Which is the larger company: GALT or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.83B compared to $168.52M for GALT.
Should I buy GALT or BIIB in 2026?
Both GALT and BIIB have investment merit. GALT trades at $2.26 while BIIB trades at $176.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GALT and BIIB stock?
Key differences: Market Cap ($168.52M vs $25.83B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).